C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
12/2006
12/14/2006	WO2006132436A1 Heterocyclic compound
12/14/2006	WO2006131340A2 Pyrrolones that act as peptide deformylase (pdf) inhibitors
12/14/2006	WO2006131304A2 Process for preparing renin inhibitors
12/14/2006	WO2006131303A2 Peptide deformylase (pdf) inhibitors 4
12/14/2006	WO2006081554A3 Phenyl-substituted pyrrolidones
12/14/2006	WO2006014913A3 Inhibitors of 5'-methylthioadenosine phosphorylase and 5'methylthioadenosine/s-adenosylhomocysteine nucleosidase
12/14/2006	US20060281928 Process for rectifying n-vinyl-2-pyrrolidone
12/14/2006	US20060281927 Process for production of cis-4-fluoro-l-proline derivatives
12/14/2006	US20060281734 3-[5-(3-acetamidobenzamido)-2-methylphenyl]-6-(4-methylpiperazin-1-yl)-3,4-dihydroquinazolin-4-one for example; treating rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease; inhibitor of cytokine-mediated disease
12/14/2006	US20060281731 3,4,5-trihydroxy-2-methoxy-8,8-dimethyl-non-enoic acid ((3S,6S)-6-azido-2-oxo-azepan-3-yl)-amide; less toxicity, better selectivity in killing cancer cells, minimal effect on normal healthy cells
12/14/2006	US20060281727 (Cycloalkyleneiminocarbonyl)-indanyl- or -tetrahydronaphthyl- methylamines, e.g., {(1S)-1-[(1S)-5-(4-Fluorophenyl)-2,3-dihydro-1H-inden-1-yl]-2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethyl}amine hydrochloride; particularly for treating type 2 diabetes
12/14/2006	US20060281629 Catalyzing the oxidation, carbonylation, nitration, sulfonation reaction; catalyst selectivity; produce terephthalic acid from p-xylene or from p-toluic acid; produce pyromellitic acid from durene
12/14/2006	US20060280746 (1E)-1-{[(3-amino-4-methoxyphenyl)methyl]sulfinyl}-2-(2,4,6-trimethoxyphenyl)ethene; antiproliferative agents; offers protection from the cytotoxic effects of ionizing radiation and of cytotoxic chemotherapeutic agents
12/14/2006	DE102005026231A1 Peptid-Deformylase (PDF) Inhibitoren 3 Peptide deformylase (PDF) inhibitors 3
12/14/2006	DE102005025315A1 Ionische Flüssigkeiten mit niedriger Viskosität Ionic liquids with low viscosity
12/14/2006	CA2610655A1 Cyclobutyl amine derivatives
12/14/2006	CA2610304A1 Peptide deformylase (pdf) inhibitors 4
12/14/2006	CA2610172A1 Heterocyclic compound
12/14/2006	CA2608575A1 Process for preparing renin inhibitors
12/13/2006	EP1731505A1 Alkoxyphenylpropanoic acid derivatives
12/13/2006	EP1730165A1 Inhibitors of hepatitis c virus ns3 protease
12/13/2006	EP1730125A2 Substituted hydroxyethylamine aspartyl protease inhibitors
12/13/2006	EP1730109A1 Synthesis of pyrrole-2-carbonitriles
12/13/2006	EP1729815A2 Pegylated ion channel modulating compounds
12/13/2006	EP1729814A2 Pegylated ion channel modulating compounds
12/13/2006	EP1729774A1 Pyrrolidine compounds
12/13/2006	EP1729773A1 8-hydroxy-5- [(-hydroxy-2- [[ (1r)-2-(4-methoxyphenyl)-1-methylethyl] amino ][ethyl -2(1h)-quinolinone monohydrochloride in crystalline form and the process for its preparation
12/13/2006	CN1876629A Preparation method of amorphous atorvastatin calcium
12/13/2006	CN1289501C Fused heterotricyclic compound, process for preparing compounds and drugs containing the same
12/13/2006	CN1289482C Organic acid salt of amlodipine
12/13/2006	CN1289481C Biphenylcarboxamides useful as lipid lowering agents
12/13/2006	CN1289472C Hydroxamic acid derivatives and medicinal utilization thereof
12/13/2006	CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006	CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
12/13/2006	CN1289451C Di-ether used in preparation of Ziegler-Natta catalyst
12/12/2006	US7148362 Process for the preparation of enantiopure pyrrolidin-2-one derivatives
12/12/2006	US7148361 Synthesis of phosphono-substituted porphyrin compounds for attachment to metal oxide surfaces
12/12/2006	US7148347 Reacting macrocyclic amide compound with hydroxy naphthalene or hydroxy quinoline derivative in a polar non-protic organic solvent in the presence of an organic or inorganic base
12/12/2006	US7148335 Mono- and bis-hydrazone pigments
12/12/2006	US7148259 hydroxyamidines; antibiotic resistance
12/12/2006	US7148251 D-t-3',4'-ethylenedioxy-p4 derivatives; glucosyl ceramide inhibitors lower glycosphingolipid levels; anticarcinogenic, antitumor agents; angiogenesis inhibitors; tumor antigens
12/12/2006	US7148242 N-formyl hydroxylamine compounds, compositions and methods of use
12/12/2006	US7148225 Treating rheumatoid arthritis, psoriasis, reperfusion injury, cardiovascular , autoimmune, inflammatory disorders and bronchial asthma
12/12/2006	US7148198 Antibacterial agents
12/07/2006	US20060276673 Process for producing amino acid derivatives
12/07/2006	US20060276530 AMPO spin traps
12/07/2006	US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/07/2006	US20060276514 Tyrosine kinase inhibitors
12/07/2006	US20060276487 New compounds useful for DPP-IV enzyme inhibition
12/07/2006	US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
12/07/2006	US20060276467 Sodium channel modulators
12/07/2006	US20060276409 N-Hydroxy-N-(1-(2-carbamoylalkylaminocarbonyl)ethyl)formamides: [(Formyl-hydroxy-amino)-methyl]-3-cyclopentyl-propionic acid (1-dimethyl-carbamoyl-2,2-dimethyl-propyl)-amide; bacterial polypeptide deformylase inhibitors
12/07/2006	US20060275750 Bioreactive agents
12/07/2006	US20060275683 photoreceptor free of an image defect such as a black spot; polycarbonate, polyether, polyester or polyurethane formed from asymmetric bis-hydroxyenamine p-(p-hydroxyphenylvinyl)phenyl 4-(p-hydroxyphenylvinyl)naphthyl 2,2-diphenylvinylamine
12/06/2006	EP1728785A1 7-[(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-heptanoic acid ester 3,5-dioxo-acetal
12/06/2006	EP1728784A1 Fluorene derivative
12/06/2006	EP1727808A2 Biaryl amino acids and their use in dna binding oligomers
12/06/2006	EP1727804A1 N1 - ((pyrazol-1-ymethyl) -2-methylphenyl)- phatalamide derivatives and related compounds insecticides
12/06/2006	EP1727795A1 Process for the production of atorvastatin calcium in amorphous form
12/06/2006	EP1727794A1 Novel benzyl(idene)-lactam derivatives
12/06/2006	CN1874995A 2-halogen-6-alkyl-phenyl substituted tetramic acid derivatives
12/06/2006	CN1874777A 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
12/06/2006	CN1872821A Method for recovering solvent from alkine in high-grade
12/06/2006	CN1288134C Antibacterial mutilins
12/06/2006	CN1288133C Synthesis of (S)-alpha-ethyl-2-oxi-1-pentazane acetamide
12/06/2006	CN1288132C Chemical synthesis of 1-chloroformyl succinimide
12/06/2006	CN1288131C Preparation method of (S)-alpha-ethyl-2-keto-1-pyrrolidine acetamide
12/05/2006	USRE39420 1,2-Diphenylpyrrole derivatives, their preparation and their therapeutic uses
12/05/2006	USRE39419 Estrogen agonist/antagonist metabolites
12/05/2006	US7145025 Structural carotenoid analogs for the inhibition and amelioration of disease
12/05/2006	US7144965 Halogenated styrene compounds and very low-loss polymers made therefrom
12/05/2006	US7144916 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
12/05/2006	US7144915 Crystalline forms of [R-(R,R)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)
12/05/2006	US7144912 drugs such as (4-methoxy-5-(1H-indol-2yl-methylene)-2,2'-bi-1H-pyrrole) used as anticarcinogenic or antitumor agents
12/05/2006	US7144904 desferrithiocin analogs used as siderophores, for treatment of malaria in humans
12/05/2006	US7144897 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
12/05/2006	US7144881 2-(2-fluoro-phenyl)-cyclopropanecarboxylic acid[1-(2,3-dihydro-benzofuran-5-yl)-ethyl]-amide for example; for pain, migraine, neuropathic pain, bipolar disorders, convulsions, mania, epilepsy, anxiety, depression and neurodegenerative disorders
11/2006
11/30/2006	WO2006127396A1 Par2-modulating compounds and their use
11/30/2006	WO2006127300A1 SYNTHESIS OF (S)-α-ETHYL-2-OXO-1-PYRROLIDINEACETAMIDE
11/30/2006	WO2006126938A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
11/30/2006	WO2006126410A1 Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same
11/30/2006	WO2006109323B1 Preparation of [2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)] pyrrole derivatives
11/30/2006	WO2006109075A3 Hydroxybenzamide derivatives and their use as inhibitors of hsp90
11/30/2006	WO2006103045B1 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
11/30/2006	WO2006017409A3 1,3-disubstituted heteroaryl nmda/nr2b antagonists
11/30/2006	US20060270856 Process for preparation of sulfamide derivatives
11/30/2006	US20060270855 Methods of preparing retroviral proteases inhibitor intermediates
11/30/2006	US20060270847 Process for producing nitrogenous heterocyclic compound
11/30/2006	US20060270718 e.g. N-(4-{1-Hydroxy-1-[1-(2-methoxyethyl)-1H-pyrrol-2-yl]-ethyl}-phenyl)-N-methyl-benzenesulfonamide; liver X receptor (LXR) agonist; antidiabetic, antiproliferative agent; lipid, metabolic disorders, obesity, diabetes, hypercholesterolemia, atherosclerosis, hyperlipoproteinemia
11/30/2006	US20060270713 3-Aminopyrrolidines as inhibitors of monoamine uptake
11/30/2006	US20060270651 Antibacterial agents
11/30/2006	CA2609735A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphthalene derivatives modulating the 5ht6 receptor
11/29/2006	EP1726580A1 Aminophenylpropanoic acid derivative
11/29/2006	EP1725528A2 Sulphonylpyrroles as hdac inhibitors
11/29/2006	EP1725527A1 An improved preparation of atorvastatin
11/29/2006	EP1725526A2 Method for preparing pyrrolidine oximes
11/29/2006	EP1725525A1 Diphenylmethyl compounds useful as muscarinic receptor antagonists
11/29/2006	EP1725236A1 Novel m3 muscarinic acetylcholine receptor antagonists
11/29/2006	EP1032559B1 Aminoalkylphenol derivatives for treating depression and memory dysfunction
11/29/2006	EP1021406B1 Novel anandamide amidase inhibitors as analgesic agents

1 ... 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 ... 404